DA Davidson analyst Tom White reiterates Uber Technologies (NYSE:UBER) with a Buy and maintains $62 price target.
What 17 Analyst Ratings Have To Say About Biomarin Pharmaceutical
Analysts have provided the following ratings for Biomarin Pharmaceutical (NASDAQ:BMRN) within the last quarter: Bullish Somewhat Bullish Indifferent…